TODAY今日发布BMCCardiovascDisordDec01,:19(1)今日发布04篇（共计37篇）IntJEmergMedDec01,:12(1)今日发布02篇（共计06篇）CurrAtherosclerRepMar01,:21(3)今日发布02篇（共计03篇）NethHeartJEarlyRecent,Feb11,今日发布04篇CirculationFeb12,:(7)今日发布25篇AmericanJournalofCardiovascularDrugsEarlyRecent,Feb12,今日发布01篇JACCFeb19,:73(6),-今日发布22篇HerzEarlyRecent,Feb12,今日发布01篇IntJCardiovascImagingEarlyRecent,Feb12,今日发布02篇CirculationEarlyRecent,Feb12,今日发布01篇StrokeEarlyRecent,Feb12,今日发布05篇CirculationResearchEarlyRecent,Feb12,今日发布01篇CardiovascDrugsTherEarlyRecent,Feb12,今日发布03篇RECOMMEND推荐阅读01糖尿病患者多支血管重建后的长期生存率：自由随访研究JACCResearchArticleMichaelE.Farkouh,MichaelDomanski,etc.7小时前等76用户推荐阅读本文BackgroundTheFREEDOM(FutureRevascularizationEvaluationinPatientswithDiabetesMellitus:OptimalManagementofMultivesselDisease)trialdemonstratedthatforpatientswithdiabetesmellitus(DM)andmultivesselcoronarydisease(MVD),coronaryarterybypassgrafting(CABG)issuperiortopercutaneouscoronaryinterventionwithdrug-elutingstents(PCI-DES)inreducingtherateofmajoradversecardiovascularandcerebrovasculareventsafteramedianfollow-upof3.8years.Itisnotknown,however,whetherCABGconfersasurvivalbenefitafteranextendedfollow-upperiod.Freedom（糖尿病患者未来血运重建评估：多支血管疾病的最佳管理）试验表明，对于糖尿病（DM）和多支血管冠心病（MVD）患者，冠状动脉旁路移植（CABG）优于药物洗脱支架经皮冠状动脉介入治疗（P在中位随访3.8年后降低主要不良心脑血管事件的发生率。然而，尚不清楚CABG在延长随访期后是否能带来生存益处。ObjectivesThepurposeofthisstudywastoevaluatethelong-termsurvivalofDMpatientswithMVDundergoingcoronaryrevascularizationintheFREEDOMtrial.本研究的目的是在自由试验中评估糖尿病合并MVD患者冠状动脉血运重建的长期生存率。MethodsTheFREEDOMtrialrandomized1,patientswithDMandMVDtoundergoeitherPCIwithsirolimus-elutingorpaclitaxel-elutingstentsorCABGonabackgroundofoptimalmedicaltherapy.After北京有专治白癜风的吗国内成立最早的白癜风医院
